Tuberculosis and the microbiome

FromThe Lancet Respiratory Medicine in conversation with

Start listening View podcast show

Tuberculosis and the microbiome

FromThe Lancet Respiratory Medicine in conversation with

ratings:

Length:

0 minutes

Released:

Sep 4, 2019

Format:

Podcast episode

Description

Grant Theron discusses growing evidence of the importance of the lung and gut microbiomes in tuberculosis, and how this knowledge might affect the future of treatment.

Released:

Sep 4, 2019

Format:

Podcast episode

Titles in the series (100)

Editors speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Respiratory Medicine: December 07, 2012 by The Lancet Respiratory Medicine in conversation with
6 min listen
The Lancet Respiratory Medicine: February 03, 2014 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: August 11, 2014 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: May 15, 2013 by The Lancet Respiratory Medicine in conversation with
8 min listen
Cystic fibrosis detection and treatment: The Lancet Respiratory Medicine: August 10, 2016 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: March 05, 2013 by The Lancet Respiratory Medicine in conversation with
10 min listen
The Lancet Respiratory Medicine: December 23, 2013 by The Lancet Respiratory Medicine in conversation with
5 min listen
Sepsis definitions: The Lancet Respiratory Medicine, February 22, 2016 by The Lancet Respiratory Medicine in conversation with
10 min listen
The Lancet Respiratory Medicine: June 04, 2013 by The Lancet Respiratory Medicine in conversation with
6 min listen
The Lancet Respiratory Medicine: April 07, 2014 by The Lancet Respiratory Medicine in conversation with
10 min listen
Interleukin 5: The Lancet Respiratory Medicine: March 23, 2015 by The Lancet Respiratory Medicine in conversation with
5 min listen
The Lancet Respiratory Medicine: December 17, 2014 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: August 20, 2013 by The Lancet Respiratory Medicine in conversation with
5 min listen
The Lancet Respiratory Medicine: December 05, 2013 by The Lancet Respiratory Medicine in conversation with
11 min listen
The role of microbiome: The Lancet Respiratory Medicine: January 2016 by The Lancet Respiratory Medicine in conversation with
9 min listen
Eosinophils and asthma: The Lancet Respiratory Medicine: November 2, 2015 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: October 22, 2013 by The Lancet Respiratory Medicine in conversation with
15 min listen
Fibrotic interstitial lung diseases: The Lancet Respiratory Medicine: May 12, 2015 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: January 27, 2014 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: December 05, 2013 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: July 19, 2013 by The Lancet Respiratory Medicine in conversation with
13 min listen
Air pollution and asthma: The Lancet Respiratory Medicine: Nov 12, 2015 by The Lancet Respiratory Medicine in conversation with
8 min listen
The Lancet Respiratory Medicine: October 25, 2013 by The Lancet Respiratory Medicine in conversation with
8 min listen
The Lancet Respiratory Medicine: March 24, 2014 by The Lancet Respiratory Medicine in conversation with
14 min listen
Pleural disease: The Lancet Respiratory Medicine: July 6, 2015 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: April 10, 2014 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: June 25, 2014 by The Lancet Respiratory Medicine in conversation with
11 min listen
Life-support: The Lancet Respiratory: June 1, 2015 by The Lancet Respiratory Medicine in conversation with
33 min listen
The Lancet Respiratory Medicine: December 2, 2014 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: May 13, 2014 by The Lancet Respiratory Medicine in conversation with
10 min listen

More Episodes from The Lancet Respiratory Medicine in conversation with

Skip carousel

Eric Lim on treatments for pleural mesothelioma by The Lancet Respiratory Medicine in conversation with
6 min listen
Anne Chang on the burden of chronic respiratory diseases in Indigenous people by The Lancet Respiratory Medicine in conversation with
10 min listen
Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC by The Lancet Respiratory Medicine in conversation with
10 min listen
Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID by The Lancet Respiratory Medicine in conversation with
8 min listen
Sarah Gorst and Tim Nicholson on long COVID outcomes by The Lancet Respiratory Medicine in conversation with
16 min listen
Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19 by The Lancet Respiratory Medicine in conversation with
12 min listen
Keith Chappell on a bivalent recombinant vaccine for COVID-19 by The Lancet Respiratory Medicine in conversation with
8 min listen
James Chalmers on bronchiectasis across Europe by The Lancet Respiratory Medicine in conversation with
12 min listen
Richard Costello on management of uncontrolled asthma by The Lancet Respiratory Medicine in conversation with
12 min listen
Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer by The Lancet Respiratory Medicine in conversation with
6 min listen
Carol Hodgson on post-discharge outcomes for ECMO patients by The Lancet Respiratory Medicine in conversation with
19 min listen
Emma Grainger on 10 years of The Lancet Respiratory Medicine by The Lancet Respiratory Medicine in conversation with
13 min listen
Vivienne Kahlmann and Catharina Moor on the TIRED study by The Lancet Respiratory Medicine in conversation with
9 min listen
Yves Lacasse on long-term oxygen therapy for COPD by The Lancet Respiratory Medicine in conversation with
17 min listen
Rachael Evans on living with long COVID by The Lancet Respiratory Medicine in conversation with
13 min listen
Daniel Munblit and Dale Needham on core outcomes post-COVID-19 by The Lancet Respiratory Medicine in conversation with
17 min listen
Daiana Stolz on antibiotic stewardship in pneumonia by The Lancet Respiratory Medicine in conversation with
10 min listen
Ablo Wachinou on sleep disordered breathing in Benin by The Lancet Respiratory Medicine in conversation with
11 min listen
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID by The Lancet Respiratory Medicine in conversation with
15 min listen
Dinh Bui on preterm birth and lung function deficits by The Lancet Respiratory Medicine in conversation with
6 min listen
Ruvim Izĭckson on a joint flu and COVID-19 vaccine by The Lancet Respiratory Medicine in conversation with
9 min listen
Wisia Wedzicha on a vaccine for COPD by The Lancet Respiratory Medicine in conversation with
9 min listen
Eileen Rubin on patient-centered ARDS by The Lancet Respiratory Medicine in conversation with
17 min listen
Daniel Altmann on COVID boosters by The Lancet Respiratory Medicine in conversation with
16 min listen
Michael Kreuter on interstitial lung disease by The Lancet Respiratory Medicine in conversation with
8 min listen
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19 by The Lancet Respiratory Medicine in conversation with
12 min listen
Charles Sprung and authors on end-of-life practices in ICUs globally by The Lancet Respiratory Medicine in conversation with
16 min listen
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma by The Lancet Respiratory Medicine in conversation with
13 min listen
Paul Verweij on COVID-19 associated aspergillosis by The Lancet Respiratory Medicine in conversation with
7 min listen
Ignacio Rubio on COVID-19 pathophysiology and phenotypes by The Lancet Respiratory Medicine in conversation with
9 min listen

Related podcast episodes

Skip carousel

Saving Lives in 3D – Lorenzo Moroni, Professor of Biofabrication, Regenerative Medicine, Maastricht University – Boundless Biofabrication: Advances in Drug Therapy and What the Future Holds for Regenerative Medicine: Kidney failure? No problem. Need a new heart? Check, working on it. Let’s just head on over to the 3D printer and print one up and send you on your way. While this sounds like science fiction, and currently still is, the advances in biofabrication... by Finding Genius Podcast
24 min listen
E82: Genetics and the skin: Past, present and future: How is genetics changing clinical practice in dermatology? What can be achieved with gene editing? What does the future of clinical genetics look like? In today’s episode, Prof. John McGrath and Prof. Regina Betz are discussing how dermatology and ge... by EADV Podcast
30 min listen
Episode: 50 - Pivoting Research with Antibody Drug Conjugates by The Chain: Protein Engineering Podcast
31 min listen
Effective Patient‒Provider Communication for PrEP Persistence: Tony Brown, MPH, an HIV pre-exposure prophylaxis (PrEP) user and advocate, discusses the importance of open and honest patient‒provider communication to support PrEP persistence. by CCO Infectious Disease Podcast
5 min listen
Harnessing the Microbiome to Understand Rheumatic Diseases: There is growing evidence - both in animal models and humans - to suggest the significant role of the microbiome in the etiology of rheumatic diseases. Over the years, multiple microbial agents and changes in the composition of the microbiota have... by Rheum Advisor on Air
25 min listen
Toxicity & Disease – Thomas Hartung, MD, Johns Hopkins Bloomberg School of Public Health – New Technology Advances to Improve Toxicity Testing and Disease Modeling: Thomas Hartung, MD, Johns Hopkins Bloomberg School of Public Health, delivers an insightful overview of his work studying toxicity testing improvements, organoids, and advancing technologies. Dr. Hartung has departmental affiliations with the... by Finding Genius Podcast
38 min listen
Maximizing mRNA With Precision Nanosystems' James Taylor, Ph.D. by Business Of Biotech
42 min listen
SCCM Pod-504 CCM: Baricitinib or Tocilizumab for Severe COVID-19: SCCM Pod-504 CCM: Baricitinib or Tocilizumab for Severe COVID-19 by SCCM Podcast
22 min listen
Decoding Non-Coding RNA: A Closer Look at the Role of MicroRNA—Shervin Takyar, MD, PhD—Yale School of Medicine: Shervin Takyar, MD, PhD, is an associate professor at Yale School of Medicine who joins the show today to discuss (miRNA). Tune in to learn the following: What role play in cell-to-cell communication How the identification of a particular has shed... by Finding Genius Podcast
40 min listen
Expression of Life – Dr. John Torday, MSc, PhD, Professor of Pediatrics and Ob/Gyn, Harbor-UCLA – Discussing the Intricate Details of Biological Development and Life: Dr. John Torday, MSc, PhD, Professor of Pediatrics and Ob/Gyn, Harbor-UCLA, Division of Neonatology, discusses biomedical research, genomics, and life. Dr. Torday’s extensive career in medicine and education has afforded him some choice... by Finding Genius Podcast
22 min listen
Community-Acquired Pneumonia with Dr. Anna Thorner: Community-acquired pneumonia is one of the most commonly encountered infections in the hospital setting. In this interview, Dr. Anna Thorner discus... by Curbside Consults
46 min listen
Carcinogenic Conditions: James DeGregori Talks Tissue Environment and Cancer Prevention: Controlling cancer depends on controlling tissue microenvironments, according to researcher James DeGregori. “There's going to be pressure on cells in the lungs of a smoker to adapt to that new environment,” he explains, “and by adapting to it,... by Finding Genius Podcast
36 min listen
Surgical site infection, quality improvement and patient involvement with Sinéad Horgan: In this episode, Martin Kiernan talks to Sinèad Horgan, Director of Nursing South/South West Hospital Group, and School of Nursing and Midwifery, College of Medicine and Health, University College Cork in Ireland. We discuss a journey towards surgica... by Infection Control Matters
27 min listen
Microbial Machination–Jamie S. Foster, Professor, Microbiology & Cell Science, University of Florida – The Artful Existence of the Microbe: Jamie S. Foster, Professor, Microbiology & Cell Science, University of Florida, provides an interesting overview of the many benefits of microbes. Dr. Foster’s research program is keenly interested in and focused on, the cooperation and... by Finding Genius Podcast
39 min listen
Neuropathologic Burden and Dementia in Nonagenarians and Centenarians: Dr. Gregg Day talks with Drs. Thomas J. Montine and Brenna Cholerton about whether the association between neuropathologic burden and dementia in these older groups differs substantially from those seen in younger-old adults. Read the related article... by Neurology® Podcast
18 min listen
Neuropathologic Burden and Dementia in Nonagenarians and Centenarians: Drs. Gregg Day, Thomas Montine, and Brenna Cholerton discuss whether the association between neuropathologic burden and dementia in these older groups differs substantially from those seen in younger-old adults. Show reference: by Neurology Minute
2 min listen
Stem Cell Manipulation – Donny Hanjaya-Putra, Assistant Professor at the University of Notre Dame – Utilizing Contemporary Engineering Principles to Control Stem Cell Differentiation, Cellular Repair, and Drug Therapy: Donny Hanjaya-Putra, assistant professor at the University of Notre Dame, discusses his research and work in the field of stem cell therapy. Hanjaya-Putra is an assistant professor in the Department of Aerospace and Mechanical Engineering at the... by Finding Genius Podcast
35 min listen
GMOs: The State of the Science: Any discussion of genetically modified organisms (GMOs) is fraught with difficulty, not least of which is the definition. describes them as “organisms whose genetic material has been artificially manipulated in a laboratory through genetic... by Nourish Balance Thrive
47 min listen
Evolving Leadership in Medicine: A Conversation with Dean Goldberg by Life of Flow
61 min listen
Testing for Cancer – Gregory Kuehn, MBA, President and COO of Prescient Metabiomics – Colon Cancer, the Microbiome, Testing: Gregory Kuehn, MBA, President and COO of Prescient Metabiomics, formerly Metabiomics, discusses their innovative work in colorectal and the development of an advanced stool test for cancer. Kuehn holds an MBA from the University of Colorado and a BS... by Finding Genius Podcast
23 min listen
Musings of the Microbiome—Michael G. Surette—Professor, Division of Gastroenterology at McMaster University, Michael G. Surette Laboratory: As a and professor at McMaster University, Michael G. Surette, PhD centers his work on a variety of aspects of the human microbiome, including its development and role in early life, what happens to it with age, and how it’s related to... by Finding Genius Podcast
41 min listen
Invisible Extinction: The Loss of Our Microbes with Maria Gloria Dominguez-Bello and Martin Blaser: Dr. Maria Gloria Dominguez-Bello, Henry Rutgers Professor of Microbiome and Health and director of the Rutgers-based New Jersey Institute for Food, Nutrition and Health, and Dr. Martin Blaser, Professor of Medicine and Pathology and Laboratory... by Meet the Microbiologist
49 min listen
The Magical Microbiome – Andres M. Gomez, Microbiomics, University of Minnesota – Microbiome Research, Health, Nutrition, Disease: In this podcast, Andres M. Gomez, University of Minnesota, discusses his research in the area of microbiomics. Gomez talks in detail about his field of microbiomics. As he explains, within microbiomics they use many and various techniques to study... by Finding Genius Podcast
37 min listen
Episode 135: Dr. Josh Turknett: We are joined on the show today by Dr. Josh Turknett. Dr Turknett graduated from Emory University School of Medicine, did his residency in neurology at the University of Florida. He is the author of two books: The Migraine Miracle and Keto For... by Low Carb MD Podcast
59 min listen
Mapping Metastasis with Sakari Vanharanta, MD, PhD: Dr. Sakari Vanharanta is a principal investigator at MRC Cancer Unit, University of Cambridge, where he studies cancer metastasis. In this episode, you will learn: What the seed and soil hypothesis is in the study of cancer, and why it could shed... by Finding Genius Podcast
32 min listen
Sir Peter Donnelly, Genomics Plc by Theory and Practice
51 min listen
Peter Hotez, MD, PhD, on the omicron variant and Delta winter surge: AMA CXO Todd Unger discusses the new omicron variant and what it means for the months ahead with good friend of the show, Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston. by AMA Update
18 min listen
MicroRNAs in Human Cancers with Researcher George Calin: Ninety-eight percent of the human genome is non-coding. The majority of our DNA instructs and regulates the other two percent. Until recently, this ninety-eight percent was considered junk DNA and held a mystery of purpose akin to dark matter. ... by Finding Genius Podcast
39 min listen
Prognostic impact of NPM1 and FLT3 mutations in AML, progression of monoclonal B cell lymphocytosis, and creating RBCs with rare blood types in the laboratory: In this week’s episode we’ll learn more about the prognostic impact of NPM1 and FLT3 mutations in AML, discuss the progression and survival of monoclonal B-cell lymphocytosis, and learn more about the use of red blood cells derived from pluripotent stem c by Blood Podcast
21 min listen
How to fix the challenges of community oncology: In this episode, we discuss community oncology and social media’s role in sharing knowledge. The OncBrothers, Dr. Rahul and Dr. Rohit Gosain, share their experiences working in the field and using social media to connect with colleagues. They emphasi... by Target: Cancer Podcast
45 min listen

Discover this podcast and so much more

Tuberculosis and the microbiome

Tuberculosis and the microbiome

Description

Titles in the series (100)

More Episodes from The Lancet Respiratory Medicine in conversation with

Related podcast episodes